A prognostic model for survival after salvage treatment with FLAG-Ida plus /- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia Academic Article 2016

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84987703584&doi=10.1111%2fbjh.14107&partnerID=40&md5=562e13da2ac5033f806aef75637f59c3

Overview
Additional Document Info
Ver todos

authors

FERNANDEZ ABELLAN, PASCUAL

publication date

2016

published in

BRITISH JOURNAL OF HAEMATOLOGY Journal